Are Analysts Bearish Masimo Corporation (NASDAQ:MASI) After Last Week?

January 21, 2018 - By Ellis Scott

 Are Analysts Bearish Masimo Corporation (NASDAQ:MASI) After Last Week?
Investors sentiment increased to 1.18 in 2017 Q3. Its up 0.07, from 1.11 in 2017Q2. It increased, as 33 investors sold Masimo Corporation shares while 92 reduced holdings. 35 funds opened positions while 112 raised stakes. 42.22 million shares or 0.82% less from 42.57 million shares in 2017Q2 were reported.
Northcoast Asset Management Limited Liability Com holds 38,656 shares or 0.39% of its portfolio. Breton Hill Ltd holds 0.14% or 9,037 shares in its portfolio. Strs Ohio has 0.01% invested in Masimo Corporation (NASDAQ:MASI) for 19,700 shares. Chicago Equity Prtn Ltd Limited Liability Company has invested 0.27% in Masimo Corporation (NASDAQ:MASI). Whittier Trust holds 0.02% or 6,644 shares in its portfolio. Soros Fund Limited Co owns 2,700 shares or 0.01% of their US portfolio. Ajo Limited Partnership invested 0.01% of its portfolio in Masimo Corporation (NASDAQ:MASI). Bowling Portfolio Llc holds 10,932 shares. Arrowstreet Cap Partnership reported 1.11 million shares. Gsa Capital Prtn Ltd Liability Partnership accumulated 15,469 shares. Bluemountain Mngmt Lc stated it has 25,732 shares or 0.05% of all its holdings. 28,890 are held by One Natl Association. Laurion Capital Mgmt L P holds 28,430 shares. Globeflex Capital Ltd Partnership accumulated 25,015 shares or 0.62% of the stock. Ing Groep Nv reported 5,852 shares.

Since August 17, 2017, it had 0 insider buys, and 2 sales for $1.84 million activity. 11,000 shares valued at $959,750 were sold by FITCH SANFORD on Thursday, August 17.

Masimo Corporation (NASDAQ:MASI) Ratings Coverage

Among 8 analysts covering Masimo (NASDAQ:MASI), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Masimo had 14 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, August 14 by BTIG Research. The firm earned “Buy” rating on Monday, July 10 by Stifel Nicolaus. The firm has “Hold” rating given on Tuesday, October 31 by Piper Jaffray. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, August 3 report. As per Wednesday, August 5, the company rating was maintained by TH Capital. As per Monday, February 27, the company rating was maintained by Wedbush. The firm has “Hold” rating by Piper Jaffray given on Thursday, September 21. Piper Jaffray maintained the shares of MASI in report on Wednesday, August 2 with “Hold” rating. The stock of Masimo Corporation (NASDAQ:MASI) has “Buy” rating given on Thursday, August 3 by Roth Capital. The rating was downgraded by Raymond James to “Mkt Perform” on Monday, February 13. Below is a list of Masimo Corporation (NASDAQ:MASI) latest ratings and price target changes.

31/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $83.0 Maintain
21/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $83.0 Maintain
14/08/2017 Broker: BTIG Research Old Rating: Neutral New Rating: Buy Upgrade
03/08/2017 Broker: Roth Capital Rating: Buy New Target: $105.0000 Maintain
02/08/2017 Broker: Piper Jaffray Rating: Hold New Target: $83.0000 Maintain
03/08/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $108.0000 Maintain

The stock increased 2.62% or $2.26 during the last trading session, reaching $88.56. About 453,297 shares traded or 14.22% up from the average. Masimo Corporation (NASDAQ:MASI) has risen 77.37% since January 21, 2017 and is uptrending. It has outperformed by 60.67% the S&P500.

Masimo Corporation, a medical technology company, develops, makes, and markets noninvasive monitoring technologies worldwide. The company has market cap of $4.58 billion. The firm offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It has a 14.2 P/E ratio. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.

More important recent Masimo Corporation (NASDAQ:MASI) news were published by: Streetinsider.com which released: “Masimo Corp. (MASI) Reports CE Marking, Release of Oxygen Reserve Index …” on January 02, 2018, also Seekingalpha.com published article titled: “Masimo: Amazing Company, But Expensive Stock”, Fool.com published: “Masimo Corporation’s Mighty Momentum Continues in 3rd Quarter” on October 31, 2017. More interesting news about Masimo Corporation (NASDAQ:MASI) was released by: Streetinsider.com and their article: “Masimo Corp. (MASI) Announces FDA Clearance for Home Use of Rad-97” with publication date: January 09, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: